SUN PHARM INDUSTRIES Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUN PHARM INDUSTRIES, and when can generic versions of SUN PHARM INDUSTRIES drugs launch?
SUN PHARM INDUSTRIES has one hundred and sixty-seven approved drugs.
There is one US patent protecting SUN PHARM INDUSTRIES drugs. There are two tentative approvals on SUN PHARM INDUSTRIES drugs.
There are twenty-two patent family members on SUN PHARM INDUSTRIES drugs in eighteen countries and one hundred and twenty-seven supplementary protection certificates in sixteen countries.
Summary for SUN PHARM INDUSTRIES
International Patents: | 22 |
US Patents: | 1 |
Tradenames: | 100 |
Ingredients: | 97 |
NDAs: | 167 |
Drugs and US Patents for SUN PHARM INDUSTRIES
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharm Industries | TRIMETHOPRIM | trimethoprim | TABLET;ORAL | 070494-001 | Jan 22, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Sun Pharm Industries | TETRACYCLINE HYDROCHLORIDE | tetracycline hydrochloride | CAPSULE;ORAL | 060736-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Sun Pharm Industries | PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE | amitriptyline hydrochloride; perphenazine | TABLET;ORAL | 071078-001 | Nov 12, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SUN PHARM INDUSTRIES
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sun Pharm Industries | BACTRIM | sulfamethoxazole; trimethoprim | TABLET;ORAL | 017377-001 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Try a Trial |
Sun Pharm Industries | BACTRIM DS | sulfamethoxazole; trimethoprim | TABLET;ORAL | 017377-002 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Try a Trial |
Sun Pharm Industries | BACTRIM | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 017560-001 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SUN PHARM INDUSTRIES Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Mexico | 371362 | ⤷ Try a Trial |
Japan | 2015534980 | ⤷ Try a Trial |
Canada | 2888853 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for SUN PHARM INDUSTRIES Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1506211 | 122014000071 | Germany | ⤷ Try a Trial | PRODUCT NAME: KOMBINATION VON DAPAGLIFLOZIN ODER EINEM PHARMAZEUTISCH VERTRAEGLICHEN SALZ DAVON, UND METFORMIN ODER EINEM PHARMAZEUTISCH VERTRAEGLICHEN SALZ DAVON, GESCHUETZT DURCH DAS GRUNDPATENT EP 1 506 211; REGISTRATION NO/DATE: EU/1/13/900 20140116 |
0503785 | CA 2011 00026 | Denmark | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF OLMESARTAN MEDOXOMIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE; NAT. REG. NO/DATE: 46260-46269 (DK) 20110323; FIRST REG. NO/DATE: DE 79810.00.00 20101216 |
0502314 | C300095 | Netherlands | ⤷ Try a Trial | PRODCUT NAME: TELMISARTAN, DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH VERDRAAGBAAR ZOUT, EN HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/02/213/001-010 20020419 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.